Aerie Pharmaceuticals
Utility Patents
Last updated:
List of all Aerie Pharmaceuticals patents 22 in total
Status | Patent |
---|---|
Grant | Utility: Ophthalmic compositions Filling date: 8 Sep 2025 Issue date: 19 Jul 2022 |
Grant | Utility: Aryl cyclopropyl-amino-isoquinolinyl amide compounds Filling date: 8 Sep 2025 Issue date: 26 Apr 2022 |
Grant | Utility: Combination therapy Filling date: 8 Sep 2025 Issue date: 14 Dec 2021 |
Grant | Utility: Compositions for treating glaucoma or reducing intraocular pressure Filling date: 8 Sep 2025 Issue date: 30 Nov 2021 |
Grant | Utility: Compounds, compositions and methods for treatment of myopia Filling date: 8 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Intravitreal drug delivery systems for the treatment of ocular conditions Filling date: 8 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Isoquinoline-steroid conjugates and uses thereof Filling date: 8 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Dual mechanism inhibitors for the treatment of disease Filling date: 8 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds Filling date: 8 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Combination therapy Filling date: 8 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: 6-aminoisoquinoline compounds Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 |
Grant | Utility: Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds Filling date: 8 Sep 2025 Issue date: 5 Jan 2021 |
Grant | Utility: Aryl cyclopropyl-amino-isoquinolinyl amide compounds Filling date: 8 Sep 2025 Issue date: 8 Dec 2020 |
Grant | Utility: Implant applicators and methods of administering implants Filling date: 8 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Dual mechanism inhibitors for the treatment of disease Filling date: 8 Sep 2025 Issue date: 19 May 2020 |
Grant | Utility: Rho kinase inhibitors Filling date: 8 Sep 2025 Issue date: 21 Apr 2020 |
Grant | Utility: Intravitreal drug delivery systems for the treatment of ocular conditions Filling date: 8 Sep 2025 Issue date: 21 Apr 2020 |
Grant | Utility: Combination therapy Filling date: 8 Sep 2025 Issue date: 17 Mar 2020 |
Grant | Utility: Combination therapy Filling date: 8 Sep 2025 Issue date: 25 Feb 2020 |
Grant | Utility: Process for the preparation of kinase inhibitors and intermediates thereof Filling date: 8 Sep 2025 Issue date: 4 Feb 2020 |
Grant | Utility: Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds Filling date: 8 Sep 2025 Issue date: 14 Jan 2020 |
Grant | Utility: 6-aminoisoquinoline compounds Filling date: 8 Sep 2025 Issue date: 12 Nov 2019 |
Showing 1 to 22 of 22 patents.